These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3111669)

  • 1. The effect of fluoride and calcium on spinal bone mineral content: a controlled, prospective (3 years) study.
    Hansson T; Roos B
    Calcif Tissue Int; 1987 Jun; 40(6):315-7. PubMed ID: 3111669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of the vertebral crush fracture syndrome with enteric-coated sodium fluoride tablets and calcium supplements.
    Nagant de Deuxchaisnes C; Devogelaer JP; Depresseux G; Malghem J; Maldague B
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S5-26. PubMed ID: 2187327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.
    Riggs BL; Hodgson SF; O'Fallon WM; Chao EY; Wahner HW; Muhs JM; Cedel SL; Melton LJ
    N Engl J Med; 1990 Mar; 322(12):802-9. PubMed ID: 2407957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis.
    Pak CY; Adams-Huet B; Sakhaee K; Bell NH; Licata A; Johnston C; Rubin B; Bonnick S; Piziak V; Graham H; Ballard J; Berger R; Fears W; Breslau N; Rubin C
    J Bone Miner Res; 1996 Feb; 11(2):160-8. PubMed ID: 8822339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures.
    Gutteridge DH; Stewart GO; Prince RL; Price RI; Retallack RW; Dhaliwal SS; Stuckey BG; Drury P; Jones CE; Faulkner DL; Kent GN; Bhagat CI; Nicholson GC; Jamrozik K
    Osteoporos Int; 2002; 13(2):158-70. PubMed ID: 11908491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.
    Reeve J; Davies UM; Hesp R; McNally E; Katz D
    BMJ; 1990 Aug; 301(6747):314-8. PubMed ID: 2393738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride.
    Delmas PD; Dupuis J; Duboeuf F; Chapuy MC; Meunier PJ
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S143-7. PubMed ID: 2339624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoride in serum and bone during treatment of osteoporosis with sodium fluoride, calcium and vitamin D.
    van Kesteren RG; Duursma SA; Visser WJ; van der Sluys Veer J; Backer Dirks O
    Metab Bone Dis Relat Res; 1982; 4(1):31-7. PubMed ID: 7121252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of different regimens of sodium fluoride treatment for osteoporosis on the structure, remodeling and mineralization of bone.
    Balena R; Kleerekoper M; Foldes JA; Shih MS; Rao DS; Schober HC; Parfitt AM
    Osteoporos Int; 1998; 8(5):428-35. PubMed ID: 9850350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium fluoride prevents bone loss in primary biliary cirrhosis.
    Guañabens N; Parés A; del Rio L; Roca M; Gómez R; Muñoz J; Rodés J
    J Hepatol; 1992 Jul; 15(3):345-9. PubMed ID: 1447501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring fluoride therapy in osteoporosis by dual photon absorptiometry.
    Raymakers JA; van Dijke CF; Hoekstra A; Duursma SA
    Bone; 1987; 8(3):143-8. PubMed ID: 3606905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between fluoride effects on bone histology and on bone mass in patients with postmenopausal osteoporosis.
    Harrison JE; Bayley TA; Josse RG; Murray TM; Sturtridge W; Williams C; Goodwin S; Tam C; Fornasier V
    Bone Miner; 1986 Sep; 1(4):321-33. PubMed ID: 3504712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intermittent therapy with a slow-release fluoride preparation.
    Pak CY; Sakhaee K; Zerwekh JE
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S149-55. PubMed ID: 2339625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoride therapy of type I osteoporosis.
    Devogelaer JP; Nagant de Deuxchaisnes C
    Clin Rheumatol; 1995 Sep; 14 Suppl 3():26-31. PubMed ID: 8846658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is addition of sodium fluoride to cyclical etidronate beneficial in the treatment of corticosteroid induced osteoporosis?
    Lems WF; Jacobs JW; Bijlsma JW; van Veen GJ; Houben HH; Haanen HC; Gerrits MI; van Rijn HJ
    Ann Rheum Dis; 1997 Jun; 56(6):357-63. PubMed ID: 9227164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The response of vertebral bone mineral density during the treatment of osteoporosis with sodium fluoride.
    Hodsman AB; Drost DJ
    J Clin Endocrinol Metab; 1989 Nov; 69(5):932-8. PubMed ID: 2793995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous ibandronate or sodium-fluoride--a 3.5 years study on bone density and fractures in Crohn's disease patients with osteoporosis.
    Klaus J; Reinshagen M; Herdt K; Adler G; von Boyen GB; von Tirpitz C
    J Gastrointestin Liver Dis; 2011 Jun; 20(2):141-8. PubMed ID: 21725510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis.
    Mamelle N; Meunier PJ; Dusan R; Guillaume M; Martin JL; Gaucher A; Prost A; Zeigler G; Netter P
    Lancet; 1988 Aug; 2(8607):361-5. PubMed ID: 2899773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmenopausal osteoporosis: treatment with low-dose sodium fluoride and estrogen.
    Lueg MC
    South Med J; 1988 May; 81(5):597-600. PubMed ID: 2835819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iatrogenic fluorosis.
    Grennan DM; Palmer DG; Malthus RS; Matagni MF; de Silva RT
    Aust N Z J Med; 1978 Oct; 8(5):528-31. PubMed ID: 283775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.